Mode
Text Size
Log in / Sign up

Clinical Trial Search

Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.

Phase
Intervention
Population
Results posted

65,437 trials

Phase 1 N=48 S1312, Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Leukemia

Acute Leukemias of Ambiguous Lineage · B-cell Adult Acute Lymphoblastic Leukemia · Philadelphia Chromosome Positive Adult Precursor Acute Lymphoblastic Leukemia
Primary: MTD of Inotuzumab Ozogamicin With CVP for Patients With Relapsed or Refractory CD22+ Acute Leukemia — 0.8; 0.5; 0.5 mg/m^2
SWOG Cancer Research Network Results Apr 2022 43.8% serious AE View details

N/A N=5,565 Japanese Pradaxa PMS, Long Term

Atrial Fibrillation
Primary: Percentage of Patients With Suspected Adverse Drug Reactions (ADRs) — 10.69 Percentage of participants
Boehringer Ingelheim Results Apr 2022 7.6% serious AE View details

Phase 2 N=84 Cx611-0204 SEPCELL Study

Bacterial Pneumonia
Primary: Number of Participants Reporting One or More Treatment-emergent Adverse Events (TEAEs) — 37; 40 Participants
Tigenix S.A.U. Results Apr 2022 53.0% serious AE View details

N/A N=12 Movement-based Infant Intervention

Infant Development · Infant,Premature · Infant, Very Low Birth Weight
Primary: Movement Rate — 1278 average leg movements per hour awake
University of Southern California Results Apr 2022 0.0% serious AE View details